Hm Payson & CO Novavax Inc Transaction History

Hm Payson & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	BUY	$6.67 - $9.52 $433 - $618	65 Added 5.38%	1,273 $9,000
Q4 2021 Feb 15, 2022	BUY	$134.56 - $217.97 $1,211 - $1,961	9 Added 0.75%	1,208 $173,000
Q3 2021 Nov 30, 2021	SELL	$177.8 - $270.58 $35,560 - $54,116	-200 Reduced 14.3%	1,199 $249,000
Q4 2020 Mar 10, 2021	BUY	$78.74 - $139.5 $314 - $558	4 Added 0.29%	1,399 $156,000
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $2,702 - $16,303	195 Added 16.25%	1,395 $116,000
Q1 2020 Jul 01, 2020	BUY	$3.93 - $16.0 $4,716 - $19,200	1,200 New	1,200 $16,000

284

83.2M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.01B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.